Earnings Review · 29 October 2026
The print
Results are in but not yet verified against a primary source in our ledger; this review updates the moment the audited figures land. What does not change is our read below.
How the market took it
On 2026-10-29 the shares closed at $94.03, +1.2% against the prior close of $92.88 (opening +1.6% from the prior close). Across the last 24 reports the shares have moved an average of +1.1% over the five sessions after the print, so the +1.2% on the day sits ahead of that average.
Did the flow confirm the move?
Underlying money flow is neutral (21-day Chaikin Money Flow -0.21, five-day price change +2.8%, as of 2026-10-28, desk flow model): no strong accumulation or distribution signature.
Give the business its due
The business itself is genuinely strong: revenue growing about 28%, net margins near 9%, a narrow competitive moat, backed by a 14% return on equity.
Levels that matter
At $94.03 the shares sit 0% below the 52-week high of $94.17 and 55% above the low of $60.58 (100% of the way up the range). The 50-day average is $89.14, below the price. The 200-day average is $84.36, below the price.
The valuation lens
The shares trade close to our fair-value estimate (+2% margin of safety): fairly priced, little cushion for a miss. Fair value lands near $96 against a $94.03 share price, a margin of safety of about 2%. The trailing multiple sits around 11 times earnings, which only makes sense if the growth holds.
The ethical lens, our differentiator
Screens compliant (on our anchor standard; the faith-based screen is stricter here). A name values-conscious investors can weigh on the merits.
The verdict for a values-conscious investor
It clears the screen; size it to your own risk and conviction. One quarter, strong or soft, does not decide whether a holding is suitable.
This is analysis, not financial advice. Always manage your risk.
